US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies
Patent 7041292 was granted and assigned to Genentech on May, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Nov, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+105 characters)
Article
Patent abstract
The present application discloses treatment of prostate cancer with anti-ErbB2 antibodies.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Mark X. Sliwkowski0
Date of Patent
May 9, 2006
0Patent Application Number
096028000
Date Filed
June 23, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies
Find more entities like US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
